Procter & Gamble Health share news, announcements and annual reports
NSE: PGHLBSE: 500126Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹5,670.50.
2 Nov: open ₹5,655.50, high ₹6,036.50, low ₹5,614.50
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹9,674 Cr585th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 25.47
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 14.70
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 3.52%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 59.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 72.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 84,74720.3% delivered
Procter & Gamble Health share news and announcements
564 announcements, routine notices left out, newest first. Page 6 of 12.
Apr 2020
9 Apr · Legal
The exchange asked on 8 Apr 2020
Mar 2020
25 Mar · Strikes/Lockouts/Disturbances
17 Mar · Change in Company Secretary/Compliance Officer
Feb 2020
25 Feb · Related Party Transactions
7 Feb · Management
7 Feb · Board meeting
7 Feb · Results
Dec 2019
31 Dec · Board meeting
23 Dec · Updates
20 Dec · Updates
Nov 2019
14 Nov · Updates
7 Nov · Board meeting
7 Nov · Results
Oct 2019
Sep 2019
6 Sep · Related Party Transactions
Aug 2019
8 Aug · Results
8 Aug · Board meeting
Jul 2019
Jun 2019
28 Jun · Management
26 Jun · Corrigendum
26 Jun · Updates
4 Jun · Name and Symbol Change
Members of the Exchange are hereby informed that the name of Merck Limited shall be changed to Procter & Gamble Health Limited and symbol shall be changed from MERCK to PGHL w.e.f. June 11, 2019.1 Jun · Meeting
May 2019
10 May · Meeting
10 May · Board meeting
10 May · Board meeting
10 May · Results
Apr 2019
2 Apr · Board meeting
Mar 2019
20 Mar · Meeting
1 Mar · Meeting
Feb 2019
27 Feb · Board meeting